Cargando…
Screening of Glypican-6 Expression in Benign, Primary and Metastatic Colon Cancers
BACKGROUND: The development of colon cancer has been described as a multistep process of carcinogenesis. Understanding molecular and cellular changes underlying this process is required to determine potential biomarkers and therapeutic targets in colon cancers. Several molecular entities, including...
Autores principales: | Al-Saraireh, Yousef M, Alshammari, Fatemah OFO, Youssef, Ahmed MM, Al-Sarayreh, Sameeh, Al-Sarayra, Yahya M, Aborajooh, Emad, Al-Shuneigat, Jehad, Alrawashdeh, Hamzeh M |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8361513/ https://www.ncbi.nlm.nih.gov/pubmed/34393539 http://dx.doi.org/10.1177/11795549211036419 |
Ejemplares similares
-
Glypican-1 Overexpression in Different Types of Breast Cancers
por: Alshammari, Fatemah O F O, et al.
Publicado: (2021) -
Cytochrome 4Z1 Expression is Associated with Poor Prognosis in Colon Cancer Patients
por: Al-saraireh, Yousef M, et al.
Publicado: (2021) -
Glypican-3 Differentiates Intraductal Carcinoma and Paget’s Disease from Other Types of Breast Cancer
por: Alshammari, Fatemah OFO, et al.
Publicado: (2022) -
Profiling of CYP4Z1 and CYP1B1 expression in bladder cancers
por: Al-saraireh, Yousef M., et al.
Publicado: (2021) -
Cytochrome 4Z1 Expression is Associated with Unfavorable Survival in Triple-Negative Breast Cancers
por: Al-saraireh, Yousef M, et al.
Publicado: (2021)